Does Increased Platelet Release Normalize During Anti-Hypertensive Treatment?

Summary

Blood platelet function was evaluated in 10 men, all 50 years old, with untreated, mild hypertension. Each patient was examined four times: At the beginning of the study, after 5 weeks on placebo treatment, after the following 5 weeks on propranolol 160 mg daily, and finally after a second period of 5 weeks on placebo. At baseline the plasma level of the platelet release product (β-thromboglobulin (BTG) was 41.6 (30.5-57.0) μg/l (median and 95% confidence interval). During the first placebo period BTG was normalized to 21.0 (14.1-25.9) μg/l. While systolic blood pressure and heart rate fell during β-adrenergic receptor blockade, BTG remained unchanged throughout the rest of the observation periods. Platelet size increased significantly during treatment with β-blocker. The present study indicates that the normalization of elevated platelet function which previously has been reported to occur during anti-hypertensive drug therapy, may be explained by patient adaptation to the blood sampling procedure.

Keywords

β-thromboglobulin - Blood pressure - Platelet size - Catecholamines - β-blocker - Thrombocytopoiesis

• References

• 1 Hamet P, Tremblay J, Hidekatsu S. Platelets in hypertension and peripheral vascular disease. In: The platelets. Physiology and pharmacology. Longenecker GL. (ed.) Academic Press; New York: 1985. pp. 367-381
• 2 Mehta J, Metha P. Platelet function in hypertension and effect of therapy. Am J Cardiol 1981; 47: 331-334
• 3 Ikeda T, Nonaka Y, Goto A, Ishii M. Effects of prazosin on platelet aggregation and beta-thromboglobulin in essential hypertension. Clin Pharmacol Therapeut 1985; 37: 601-605
• 4 Erne P, Bolli P, Burgisser E, Biihler FR. Correlation of platelet calcium with blood pressure. N Engl J Med 1984; 310: 1084-1088
• 5 Vlachakis ND, Aledort L. Hypertension and propranolol therapy: Effect on blood pressure, plasma catecholamines and platelet aggregation. Am J Cardiol 1980; 45: 321-325
• 6 Lande K, Os I, Kjeldsen SE, Westheim A, Hjermann I, Eide I, Gjesdal K. Blood platelet size, platelet release reaction and response to infused adrenaline are increased in mild essential hypertension. J Hyperten. 1986 4. suppl 6, in press
• 7 Kaplan KL, Owen J. Plasma levels of (3-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
• 8 Frojmovic M, Milton J. Human platelet size, shape and related functions in health and disease. Physiol Rev 1982; 62: 185-261
• 9 Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Vareri CR. Size dependent platelet subpopulations: Relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982; 50: 509-519
• 10 Leren P, Askevold EM, Foss OP, Frøili A, Grymyr D, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG, Norum KR. The Oslo Study. Cardiovascular disease in middleaged and Young Oslo men. Acta Med Scand 1975; 198 suppl 588
• 11 Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625-636
• 12 Kjeldsen SE, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with longstanding, untreated essential hypertension. Scand J Clin Lab Invest 1982; 42: 217-223
• 13 Brown BW, Hollander M. Introduction to Biomedical Statistics. John Wiley … Sons; New York: 1981. pp. 310-339
• 14 Conover WJ. Practical Nonparametric Statistics 2nd ed. John Wiley … Sons; New York: 1980. pp. 299-300
• 15 Kjeldsen SE, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss OP, Leren P. Increased beta-thromboglobulin in essential hypertension: Interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 1983; 213: 369-373
• 16 Petralito A, Fiore CE, Mangiafico RA, Malatino LS. Beta- thromboglobulin plasma levels in different stages of arterial hypertension. Thromb Haemostas 1982; 48: 241
• 17 Zahavi J, Kakkar VV. Beta-thromboglobulin, a specific marker of in vivo platelet release reaction. Thromb Haemostas 1980; 44: 23-29
• 18 Hollister AS, Onrot J, Lonce S, Nadeau HJ, Robertson D. Plasma catecholamine modulation of alpha2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets. J Clin Invest 1986; 77: 1416-1421
• 19 Ludlam CA. Evidence for the platelet specificity of (3-thromboglobu- lin and studies on its plasma concentration in healthy individuals. Br J Haematol 1979; 41: 271-278
• 20 Martin JF, Plumb J, Kilbey RS, Kishk YT. Changes in volume and density of platelets in myocardial infarction. Br Med J 1983; 287: 456-459
• 21 Cameron HA, Phillips R, Ibbotson RM, Carson P HM. Platelet size in myocardial infarction. Br Med J 1983; 287: 449-451
• 22 Freedman ML, Karpatkin S. Heterogeneity of rabbit platelets. V. Preferential splenic sequestration of megathrombocytes. Br J Haematol 1975; 31: 255-262
• 23 Giles C. Platelet count and mean platelet volume. Br J Haematol 1981; 48: 31-37
• 24 Pennington DG. Thrombopoiesis. In: Haemostasis and Thrombosis. Bloom AL, Duncan PT. (eds.) Churchill Livingstone; Edinburgh: 1981. pp. 1-21